On the recordApril 18, 2023
The FDA is holding an advisory committee meeting on opiates today in particular on the questionable clinical trial practice known as enriched enrollment.
Source
congress.govEditor's note · Context
Manchin discusses an FDA meeting addressing concerns about clinical trial practices.
Share
More from Joe Manchin
Dec 11, 2024
I further ask that the bill be considered read a third time and passed and that the motion to reconsider be considered made and laid upon the table with no intervening action or debate. The PRESIDING OFFICER. Without objection, it is so…
Dec 11, 2024
if there is no further business to come before the Senate, I ask that it stand adjourned under the previous order. There being no objection, the Senate, at 7:17 p.m., adjourned until Thursday, December 12, 2024, at 10 a.m…
Jul 1, 2026
My observation, and recommendation from observation, would be, John, trust me, set yourself free and become an independent.
Other voices in this conversation
